BIOLEVERAGE: sector benchmark
Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.
BIOLEVERAGE
Summary
BIOLEVERAGE does better than half of its sector on 3 of the 7 ratios compared.
- Return on equitybetter than 90%
- Return on assetsbetter than 87%
- Interest coveragebetter than 78%
- Solvencybetter than 9%
- Working-capital ratiobetter than 25%
- Current ratiobetter than 28%
Solvency and debt
Solvency is below 91% of 43,025 sector peers: in the least favourable quarter.
Position against the sector weakening since 2021.
Debt to equity is above 61% of 49,278 sector peers: less favourable than the median.
Position against the sector weakening since 2021.
Interest coverage is above 78% of 37,267 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
Liquidity
The current ratio is below 72% of 42,397 sector peers: less favourable than the median.
Position against the sector weakening since 2021.
The working-capital ratio is below 75% of 42,964 sector peers: in the least favourable quarter.
Position against the sector weakening since 2021.
Profitability
Return on equity is above 90% of 45,593 sector peers: in the most favourable quarter.
Position against the sector improving since 2021.
Return on assets is above 87% of 43,123 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
Not computable
Long-term debt ratio, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.
Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.